Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?

被引:13
|
作者
Ferrara, Felicetto [1 ]
机构
[1] Cardarelli Hosp, Div Hematol, Naples, Italy
关键词
UPDATE;
D O I
10.1038/s41408-020-0281-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study
    Yan-Yan Li
    Shuai-Shuai Ge
    Yuan-Hong Huang
    Ming-Zhu Xu
    Chao-Ling Wan
    Kai-Wen Tan
    Tao Tao
    Hai-Xia Zhou
    Sheng-Li Xue
    Hai-Ping Dai
    Blood Cancer Journal, 14
  • [42] Venetoclax plus hypomethylating agents combined with dose-adjusted HAG for relapsed/refractory acute myeloid leukemia Two case reports
    Wang, Hongxia
    Bai, Junjun
    Pei, Zhixin
    Zhang, Bei
    Wang, Junjie
    Lian, Xingli
    Song, Qinglin
    MEDICINE, 2020, 99 (47) : E23265
  • [43] Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy
    Laloi, Louise
    Billotey, Natacha Chaumard
    Dumas, Pierre-Yves
    Paul, Franciane
    Villate, Alban
    Simand, Celestine
    Fornecker, Luc
    Puisset, Florent
    Bertoli, Sarah
    Simonet, Marion Boissard
    Laribi, Kamel
    Houyou, Dyhia
    Santagostino, Alberto
    Michel, Claire
    Guepin, Gabrielle Roth
    Guerineau, Elodie
    Tabrizi, Reza
    Hunault, Mathilde
    Giltat, Aurelien
    Kaphan, Eleonore
    Bulabois, Claude
    Cartet, Elodie
    Rocher, Clement
    Lachenal, Florence
    Morisset, Stephane
    Recher, Christian
    Pigneux, Arnaud
    Belhabri, Amine
    Michallet, Mauricette
    Michallet, Anne-Sophie
    CANCER MEDICINE, 2023, 12 (06): : 7175 - 7181
  • [44] Hypomethylating Agents in Combination with Venetoclax As a Bridge to Allogeneic Transplant in Acute Myeloid Leukemia
    Kennedy, Vanessa E.
    Hui, Gavin
    Gaut, Daria
    Mittal, Varun
    Oliai, Caspian
    Muffly, Lori S.
    Logan, Aaron C.
    Mannis, Gabriel N.
    BLOOD, 2020, 136
  • [45] Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia
    Aldoss, Ibrahim
    Yang, Dongyun
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Al Malki, Monzr M.
    Mei, Matthew
    Salhotra, Amandeep
    Khaled, Samer
    Nakamura, Ryotaro
    Snyder, David
    O'Donnell, Margaret
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    HAEMATOLOGICA, 2018, 103 (09) : E404 - E407
  • [46] Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia
    Kennedy, Vanessa E.
    Hui, Gavin
    Azenkot, Tali
    Gaut, Daria
    Wieduwilt, Matthew J.
    Oliai, Caspian
    Jonas, Brian A.
    Mittal, Varun
    Logan, Aaron C.
    Muffly, Lori S.
    Mannis, Gabriel N.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : E191 - E194
  • [47] Venetoclax and hypomethylating agents inFLT3-mutated acute myeloid leukemia
    Aldoss, Ibrahim
    Zhang, Jianying
    Mei, Matthew
    Al Malki, Monzr M.
    Arslan, Shukaib
    Ngo, Dat
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Salhotra, Amandeep
    Koller, Paul
    Khaled, Samer
    Artz, Andrew
    Snyder, David
    Nakamura, Ryotaro
    Forman, Stephen J.
    Stein, Anthony S.
    Marcucci, Guido
    Pullarkat, Vinod
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (10) : 1193 - 1199
  • [48] Inpatient Versus Outpatient Administration of Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia
    Sanka, Pranavi
    Egan, Pamela
    Niroula, Rabin
    Yakirevich, Inna
    Gardner, David
    Reagan, John L.
    BLOOD, 2023, 142
  • [49] Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents
    Aldoss, Ibrahim
    Dadwal, Sanjeet
    Zhang, Jianying
    Tegtmeier, Bernard
    Mei, Matthew
    Arslan, Shukaib
    Al Malki, Monzr M.
    Salhotra, Amandeep
    Ali, Haris
    Aribi, Ahmed
    Sandhu, Karamjeet
    Khaled, Samer
    Snyder, David
    Nakamura, Ryotaro
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    BLOOD ADVANCES, 2019, 3 (23) : 4043 - 4049
  • [50] More options for older patients with acute myeloid leukemia: venetoclax in combination with low dose cytarabine
    Aldoss, Ibrahim
    Marcucci, Guido
    CHINESE CLINICAL ONCOLOGY, 2019, 8